Debiopharm Group

Debiopharm Group

Debiopharm Group

Overview
Headquarters

Chemin Messidor 5-7 Case postale 5911 Lausanne, Vaud, CH - 1002, Switzerland

Type of Company

Private

Employees (Worldwide)

501 - 1,000

Industries

Medical Support Services
Pharmaceuticals
Biotechnology

Company Description

Debiopharm Groupâ„¢ is a global biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. They develop their products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.

Executives & Employees

Co-President & Founder

Communication Coordinator

Communication Coordinator

Consultant-Press & Public Relations Officer

Director-Human Resources

Vice President-Corporate Development

Vice President of the Project & Portfolio Management Office

Paths to Debiopharm Group
Potential Connections via
Relationship Science
You
Debiopharm Group
Investments
Details Hidden

Diagnoplex SA develops molecular diagnostics for colon cancer. It lead product, Colox is a minimally-invasive blood test developed for the systematic screening and detection of early and advanced colorectal cancer. The company was founded in April 2005 by Stavros Therianos, Curzio Roberto Maria Rüegg, Jacques R. Essinger and Jean-Pierre Rosat and is headquartered in Lausanne, Switzerland.